Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

Enhancing Patient Care with Pharmacogenomics

20 February 2025
Specialized Medical Fields
Arab Health 2025

About the Speakers

  • Raya Zayadeen
    VP Pharmacy and Therapeutics, M42

  • Dr. Val Zvereff
    Laboratory Director at M42
  • Dr. Wadha Mohammed
    Toxicology & Medication Education Specialist for the Department of Health - Abu Dhabi
  • Sahar Ahmed Almarzooqi
    Specialist for the Department of Health - Abu Dhabi
  • Dr. Stephen Grobmyer
    Chairman of Oncology at Cleveland Clinic Abu Dhabi
  • Dr. Amal Alsereidi
    Scientific Committee Chairperson, Emirates Pharmacy Society/ Clinical Pharmacist, Emirates Health Services - Dibba

    Watch Next

    • Specialized Medical Fields

      Shaping the Future of Organ Transplantation: Pioneering Innovation and Technology in Complex Procedures

      20 February, 2025
      Watch Now
    • Specialized Medical Fields

      Understanding Lymphedeme: Innovations in Breast Cancer Treatment

      20 February, 2025
      Watch Now
    • Specialized Medical Fields

      Bridging IVF and Genomics: Exploring New Frontiers

      20 February, 2025
      Watch Now